Disclosures for "Comparison of B-cell Depletion and Natalizumab for Treatment of Multiple Sclerosis: A Semi-supervised Causal Analysis"
-
Mr. DiSanto has nothing to disclose.
-
Dr. Tang has nothing to disclose.
-
Dr. Zhu has nothing to disclose.
-
Tianxi Cai has nothing to disclose.
-
The institution of Dr. Xia has received research support from National Institute of Health. The institution of Dr. Xia has received research support from Department of Defense. The institution of Dr. Xia has received research support from Genentech/Roche.